NCCU COVID-19 Vaccine Clinic: Suspension of Johnson & Johnson Vaccine

Posted April 11, 2021, 1:32PM

April 13, 2021 

The NCCU COVID-19 Vaccine Clinic will suspend use of the Johnson & Johnson (Janssen) vaccine immediately until further notice following the recommendation of the U.S. Centers for Disease Control and Prevention (CDC) and Federal Drug Administration (FDA), and as directed by the North Carolina Department of Health and Human Services. The CDC and FDA are reviewing data involving six cases of individuals in the U.S. developing a rare and severe type of blood clot after receiving the J&J vaccine. It is important to know that this adverse effect is extremely rare with six cases identified out of more than 6.8 million doses of the J&J vaccine that have been administered in the United States. 

The NCCU COVID-19 Vaccine Clinic scheduled for tomorrow, Wednesday, April 14, 2021, will now administer the Moderna vaccine. Individuals with appointments already scheduled will be contacted directly.

More information will be provided when it becomes available, but please review the statement from the CDC and FDA here: https://www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html.

Please contact [email protected] with questions and visit www.nccu.edu/coronavirus for updates.

Thank you.

You May Also Like

law school students
The commission is dedicated to enhancing legal education by evaluating ABA standards, admissions, curricula, student support, clinic operations, bar passage rates and career outcomes.
Haywoods' Check Presentation at 2024 HOCO Game
The Haywoods' gift will strengthen NCCU's Hospitality and Tourism program, supporting academic excellence and practical training for future hospitality leaders.
2024 CEO Roundtable on Cancer Annual Meeting on September 25, 2024.
NCCU has received the prestigious CEO Cancer Gold Standard™ designation, recognizing its commitment to supporting and promoting employee health, cancer prevention, early detection and high-quality care.